ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31162-1mg |
|
1096485-24-3 |
Neuronostatin-13 human
|
0 | C64H110N20O16 | |
GC31161-5mg |
|
303052-45-1 |
Neuropeptide Y(29-64)
|
0 | C189H284N54O58S | |
GC31161-1mg |
|
303052-45-1 |
Neuropeptide Y(29-64)
|
0 | C189H284N54O58S | |
GC31160-100mg |
|
56-59-7 |
Felypressin (PLV-2)
|
0 | C46H65N13O11S2 | |
GC31160-50mg |
|
56-59-7 |
Felypressin (PLV-2)
|
0 | C46H65N13O11S2 | |
GC31160-10mg |
|
56-59-7 |
Felypressin (PLV-2)
|
0 | C46H65N13O11S2 | |
GC31160-5mg |
|
56-59-7 |
Felypressin (PLV-2)
|
0 | C46H65N13O11S2 | |
GC31160-2mg |
|
56-59-7 |
Felypressin (PLV-2)
|
0 | C46H65N13O11S2 | |
GC31160-10mM(1mLinDMSO) |
|
56-59-7 |
Felypressin (PLV-2)
|
0 | C46H65N13O11S2 | |
GC31159-10mg |
|
94071-26-8 |
Cerebellin
|
0 | C69H113N23O23 | |
GC31159-5mg |
|
94071-26-8 |
Cerebellin
|
0 | C69H113N23O23 | |
GC31159-1mg |
|
94071-26-8 |
Cerebellin
|
0 | C69H113N23O23 | |
GC31158-10mg |
|
1310347-50-2 |
BACE1-IN-1
|
0 | C18H14F3N5O2 | |
GC31158-5mg |
|
1310347-50-2 |
BACE1-IN-1
|
0 | C18H14F3N5O2 | |
GC31158-1mg |
|
1310347-50-2 |
BACE1-IN-1
|
0 | C18H14F3N5O2 | |
GC31157-10mg |
|
724424-43-5 |
CE-224535 (PF-04905428)
|
0 | C22H29ClN4O6 | |
GC31157-5mg |
|
724424-43-5 |
CE-224535 (PF-04905428)
|
0 | C22H29ClN4O6 | |
GC31157-1mg |
|
724424-43-5 |
CE-224535 (PF-04905428)
|
0 | C22H29ClN4O6 | |
GC31156-25mg |
|
2507-24-6 |
Physalaemin
|
0 | C58H84N14O16S | |
GC31156-10mg |
|
2507-24-6 |
Physalaemin
|
0 | C58H84N14O16S | |